ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,065Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 1571

$1.58M Total Retail Price of All Prescriptions

Rank: 22 out of 1571

680 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 680 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 680 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 24,498 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $99 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 987 958 1 1
AMLODIPINE BESYLATE 922 874 2 2
OMEPRAZOLE 730 690 3 4
LEVOTHYROXINE SODIUM 647 622 4 6
ALENDRONATE SODIUM 638 638 5 22
ATORVASTATIN CALCIUM 603 553 6 8
WARFARIN SODIUM 599 584 7 14
NEXIUM 547 508 8 39
METOPROLOL SUCCINATE 517 477 9 16
FUROSEMIDE 509 487 10 7
ZOLPIDEM TARTRATE 497 489 11 20
GABAPENTIN 450 434 12 12
METFORMIN HCL 411 354 13 9
SERTRALINE HCL 398 360 14 52
DIOVAN 385 382 15 19
HYDROCODONE-ACETAMINOPHEN 380 304 S3 16 3
METOPROLOL TARTRATE 369 357 17 13
MELOXICAM 362 355 18 49
ATENOLOL 345 342 19 15
MIRTAZAPINE 333 326 20 96
CRESTOR 333 317 20 25
TAMSULOSIN HCL 315 290 22 11
DONEPEZIL HCL 296 296 23 24
PLAVIX 266 253 24 28
ALLOPURINOL 262 252 25 36
ADVAIR DISKUS 252 246 26 43
BENAZEPRIL HCL 236 213 27 32
CELEBREX 234 234 28 71
PANTOPRAZOLE SODIUM 225 208 29 23
ESCITALOPRAM OXALATE 221 221 30 104
LIDODERM 218 215 31 95
CLOPIDOGREL 216 200 32 21
LIPITOR 215 208 33 67
DIOVAN HCT 213 213 34 64
IBUPROFEN 202 189 35 44
LISINOPRIL 198 192 36 5
VOLTAREN 189 176 37 114
POTASSIUM CHLORIDE 185 173 38 27
PAROXETINE HCL 168 154 39 100
JANUVIA 168 145 39 50
GLIMEPIRIDE 165 155 41 70
TRAMADOL HCL 163 150 42 31
POLYETHYLENE GLYCOL 3350 160 154 43 146
TRIAMCINOLONE ACETONIDE 149 146 44 55
PROAIR HFA 142 131 45 63
SINGULAIR 140 139 46 88
AZITHROMYCIN 136 123 47 58
GLYBURIDE-METFORMIN HCL 133 112 R 48 178
FLUTICASONE PROPIONATE 132 131 49 41
LEVOFLOXACIN 130 124 50 79
NASONEX 130 120 50 163
LOVAZA 129 129 52 90
CARVEDILOL 128 125 53 10
DETROL LA 126 126 54 246
LYRICA 124 122 55 127
BONIVA 123 116 56 324
DIGOXIN 122 114 57 35
ISOSORBIDE MONONITRATE ER 121 117 58 48
LEXAPRO 118 118 59 257
LOSARTAN POTASSIUM 117 106 60 17
ACTOS 116 108 61 92
NAMENDA 114 114 62 37
FAMOTIDINE 107 107 63 54
IBANDRONATE SODIUM 107 83 63 270
ZETIA 100 82 65 73
LANTUS 99 69 66 65
PREDNISONE 98 82 67 34
LOSARTAN-HYDROCHLOROTHIAZIDE 96 96 68 77
CLONIDINE HCL 96 90 68 45
AMIODARONE HCL 95 89 70 76
AVODART 95 95 70 40
ENALAPRIL MALEATE 95 88 70 81
FLUOXETINE HCL 93 70 73 112
GLYBURIDE 92 89 R 74 99
CITALOPRAM HBR 89 89 75 66
RANITIDINE HCL 88 76 76 85
LOVASTATIN 87 75 77 33
AMLODIPINE BESYLATE-BENAZEPRIL 87 78 77 135
SEROQUEL 85 80 79 270
DICLOFENAC SODIUM 83 83 80 93
CYMBALTA 81 66 81 68
OXYBUTYNIN CHLORIDE 81 81 81 235
KLOR-CON M20 80 68 83 290
ACTONEL 79 77 84 171
LEVETIRACETAM 79 66 84 60
QUETIAPINE FUMARATE 77 76 86 102
CARBIDOPA-LEVODOPA 77 74 86 51
SPIRIVA 73 73 88 56
FINASTERIDE 71 71 89 30
METOCLOPRAMIDE HCL 70 65 90 116
DOXAZOSIN MESYLATE 69 69 91 84
KLOR-CON 8 68 68 92 152
DILTIAZEM 24HR CD 67 67 93 172
INSULIN SYRINGE 66 40 94 124
ALCOHOL SWABS 65 63 95 351
MEGESTROL ACETATE 61 61 R 96 145
HYDROCHLOROTHIAZIDE 58 58 97 18
VESICARE 58 54 97 75
AMITRIPTYLINE HCL 58 17 R 97 117
LANSOPRAZOLE 58 56 97 182
OXYBUTYNIN CHLORIDE ER 56 56 101 140
DEXILANT 56 56 101 91
BUPROPION XL 55 49 103 183
VENLAFAXINE HCL ER 55 52 103 204
MECLIZINE HCL 55 55 103 162
PRAVASTATIN SODIUM 55 52 103 26
EXFORGE 54 54 107 280
SUMATRIPTAN SUCCINATE 53 41 108 329
SYNTHROID 53 53 108 59
BENICAR 53 53 108 148
ACETAMINOPHEN-CODEINE 51 49 S3 111 105
SINGLE USE SWAB 51 51 111 373
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.